-
1
-
-
10344253782
-
Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil and leucovorin in patients with metastatic colorectal cancer
-
(1996)
J Clin Oncol
, vol.14
, pp. 2950-2958
-
-
Bertheault-Cvitkovic, F.1
Jami, A.2
Ithzaki, M.3
Brummer, P.D.4
Brienza, S.5
Adam, R.6
Kunstlinger, F.7
Bismuth, H.8
Misset, J.9
Levi, F.10
-
3
-
-
0030888321
-
Oxaliplatin with high dose leucovorin and fluorouracil 48-hour continuous infusion in pre-treated metastatic colorectal cancer
-
(1997)
Eur J Cancer
, vol.33
, pp. 214-219
-
-
De Gramont, A.1
Vignoud, J.2
Tournigand, C.3
Louvet, C.4
Andre, T.5
Varette, C.6
Raymond, E.7
Moreau, S.8
Le Bail, N.9
Krulik, M.10
-
5
-
-
0031696544
-
Clinical impact of pharmacokinetically- guided dose adaptation of 5-fluorouracil: Results from a multicentric randomised trial in patients with locally advanced head and neck carcinomas
-
(1998)
Clin Cancer Res
, vol.4
, pp. 2039-2045
-
-
Fety, R.1
Rolland, F.2
Barberi-Heyob, M.3
Hardouin, A.4
Campion, L.5
Conroy, T.6
Merlin, J.L.7
Riviere, A.8
Perrocheau, G.9
Etienne, M.C.10
Milano, G.11
-
8
-
-
13344269002
-
Relationship between 5-fluorouracil dose-intensity and therapeutic response in patients with advanced colorectal cancer receiving 5-FU containing infusional therapy
-
(1996)
Cancer
, vol.77
, pp. 441-451
-
-
Gamelin, E.1
Danquechin-Dorval, E.M.2
Dumesnil, Y.F.3
Maillart, P.J.4
Goudier, M.J.5
Burtin, P.C.6
Delva, R.G.7
Lortholary, A.H.8
Gesta, P.H.9
Larra, F.G.10
-
11
-
-
0030967259
-
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients
-
(1997)
Clin Cancer Res
, vol.3
, pp. 891-899
-
-
Gamelin, E.1
Le Bouil, A.2
Boisdron-Celle, M.3
Turcant, A.4
Delva, R.5
Cailleux, A.6
Krikorian, A.7
Brienza, S.8
Cvitkovic, E.9
Robert, J.10
Larra, F.11
Allain, P.12
-
12
-
-
0031901763
-
Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: Results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients
-
(1998)
J Clin Oncol
, vol.16
, pp. 1470-1478
-
-
Gamelin, E.1
Boisdron-Celle, M.2
Delva, R.3
Regimbeau, C.4
Cailleux, P.E.5
Alleaume, C.6
Maillet, M.L.7
Goudier, M.J.8
Sire, M.9
Person-Joly, M.C.10
Maigre, M.11
Maillart, P.12
Fety, R.13
Burtin, P.14
Lortholary, A.15
Dumesnil, Y.16
Picon, L.17
Geslin, J.18
Gesta, P.19
Danquechin-Dorval, E.20
Larra, F.21
Robert, J.22
more..
-
14
-
-
0025058867
-
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion
-
(1990)
Cancer Res
, vol.50
, pp. 197-201
-
-
Harris, B.E.1
Song, R.2
Soong, S.J.3
Diaso, R.B.4
-
16
-
-
0345403552
-
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results of randomised trial in patients with advanced colorectal cancer
-
(1998)
J Clin Oncol
, vol.16
, pp. 418-426
-
-
Kohne, C.H.1
Schoffski, P.2
Wilke, H.3
Käufer, C.4
Andreesen, R.5
Ohl, U.6
Klaasen, U.7
Westerhausen, M.8
Hiddermann, W.9
Schott, G.10
Harstick, A.11
Bade, J.12
Horster, A.13
Schubert, U.14
Hecker, H.15
Dorken, B.16
Schmoll, H.J.17
-
17
-
-
0026512446
-
A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump
-
(1992)
Cancer
, vol.69
, pp. 893-900
-
-
Levi, F.1
Misset, J.L.2
Brienza, S.3
Adam, R.4
Metzger, G.5
Itzakhi, M.6
Caussanel, J.P.7
Kunstlinger, F.8
Lecouturier, S.9
Descorps-Declere, A.10
-
18
-
-
0027310715
-
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
-
(1993)
Eur J Cancer
, vol.29
, pp. 1280-1284
-
-
Levi, F.1
Perpoint, B.2
Garufi, C.3
Focan, C.4
Chollet, P.5
Depres-Brummer, P.6
Zidani, R.7
Brienza, S.8
Itzhaki, M.9
Iacobelli, S.10
-
20
-
-
0012797224
-
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
-
(1996)
Ann Oncol
, vol.7
, pp. 95-98
-
-
Machover, D.1
Diaz-Rubio, E.2
De Gramont, A.3
Schilf, A.4
Gastiaburu, J.J.5
Brienza, S.6
Itzhaki, M.7
Metzger, G.8
N'Daw, D.9
Vignoud, J.10
Abad, A.11
François, E.12
Gamelin, E.13
Marty, M.14
Sastre, J.15
Seitz, J.F.16
Ychou, M.17
-
22
-
-
0024407292
-
Oxalatoplatinum or LOHP, a third generation complex, an experimental and clinical appraisal and preliminary comparison with cisplatin and carboplatinum
-
(1989)
Biomed Pharmacother
, vol.43
, pp. 237-250
-
-
Mathé, G.1
Kidani, Y.2
Segiguchi, M.3
Eriguchi, M.4
Fredj, G.5
Peytavin, G.6
Misset, J.L.7
Brienza, S.8
De Vassals, F.9
Chenu, E.10
-
31
-
-
0024262909
-
Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule
-
(1988)
Cancer Res
, vol.48
, pp. 6956-6961
-
-
Van Groeningen, C.J.1
Pinedo, H.M.2
Heddes, J.3
Kok, R.M.4
De Jong, A.P.5
Wattel, E.6
Peters, G.J.7
Lankelma, J.8
-
32
-
-
0025171495
-
Clinical significance of monitoring serum levels of 5-fluorouracil by continuous infusion in patients with advanced colonic cancer
-
(1990)
Cancer Chemother Pharmacol
, vol.26
, pp. 352-354
-
-
Yoshida, T.1
Araki, E.2
Ligo, M.3
Fujii, T.4
Yoshino, M.5
Shimada, Y.6
Saito, D.7
Tajiri, H.8
Yamaguchi, H.9
Yoshida, S.10
|